MiRXES in 2000 participant multi-hospital study to detect liver cancer early
MiRXES in 2000 participant multi-hospital study to detect liver cancer early Read More »
Press Release
Data from pulmonary hypertension collaboration with Janssen-J&J presented at ERS Congress 2020
SINGAPORE – September 8, 2020 – MiRXES Pte Ltd, a leading microRNA (miRNA)a diagnostic company headquartered in Singapore, in collaboration with Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has presented the preliminary results of a study revealing that miRNA biomarker signatures have the potential to support early identification and
